
From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
Jennifer Athay-Adams, PharmD, discusses how the payment model of accountable care organizations (ACOs) differs from that of traditional HMOs.
In this video, Jennifer Athay-Adams, PharmD, senior director of strategic academic partnerships with the American Association of Colleges of Pharmacy, discusses how the payment model of accountable care organizations (ACOs) differs from that of traditional HMOs.




